Skip to content
Screener

VolitionRX Limited VNRX Q4 2025 Annual earnings

Reported March 31, 2026 · After market close

Revenue$420.0KMiss by $333.6K
EPS-$0.05Miss by $0.01
Revenue estimate$753.6K
EPS estimate-$0.04

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$706.4K
EPS estimate-$0.38

FAQ

When did VolitionRX Limited report Q4 2025 earnings?
VolitionRX Limited (VNRX) reported Q4 2025 earnings on March 31, 2026 after market close.
What were VolitionRX Limited's Q4 2025 revenue and EPS?
VolitionRX Limited reported revenue of $420.0K and eps of $-0.05 for Q4 2025.
Did VolitionRX Limited beat estimates in Q4 2025?
Revenue missed the consensus estimate of $753.6K by $333.6K. EPS missed the consensus estimate of $-0.04 by $0.01.
How did VolitionRX Limited's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 119.1% from $191.7K a year earlier and eps grew 16.7% from $-0.06.
Where can I find VolitionRX Limited's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001477932-26-001830) and the 10-K periodic report (0001477932-26-001832) directly on SEC EDGAR. The filing index links above go to sec.gov.